Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Squamos Cell Carcinoma of the Lung
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- 26 Sep 2017 Status changed from active, no longer recruiting to discontinued.
- 04 Sep 2005 New trial record.